Bridging biology and statistics with hybrid Bayesian experimental design for drug dose-response assays
Atlanta Chakraborty, Siyi Chen, Xun Huan, Gary D. Luker
This paper introduces a Bayesian framework for optimizing drug dose-response assays to improve information efficiency and reduce trial-and-error in cancer research.
bioRxiv · Sep 18, 2025 · PreprintCancer Biology